Third Annual Manufacturers 340B Summit

Aaron Vandervelde and Andrew Brownlee presented “Leverage Data to Identify Duplicate Discounts.” When manufacturers pay Medicaid rebates or honor commercial discounts on 340B purchased drugs, they are subject to duplicative discounts that are either prohibited by law (Medicaid) or contractual terms (commercial). Manufacturers must determine the presence of both discounts and resolve inappropriate payments.

In this session, Mr. Vandervelde and Mr. Brownlee discussed topics including new research on the volume of duplicate discounts, potential ways to leverage data to flag instances of duplicate discounts, and lessons from the field on enforcing manufacturers’ rights to prevent duplicate discounts.

Visit the event page.